These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 6795701)
1. Comparison of ftorafur with 5-fluorouracil in combination chemotherapy of advanced gastrointestinal carcinoma. Queisser W; Schnitzler G; Schaefer J; Arnold H; Drings P; Fritze D; Geldmacher J; Hartwich G; Herrmann R; Kempf P; König H; Meiser RJ; Nedden R; von Oldershausen HF; Pappas A; Sievers H; Wahrendorf J; Westerhausen M; Witte S Recent Results Cancer Res; 1981; 79():82-92. PubMed ID: 6795701 [TBL] [Abstract][Full Text] [Related]
2. [A prospective multi-centre study of the response of metastatic gastrointestinal tumours (author's transl)]. Queisser W; Schaefer J; Arnold H; Drings P; Geldmacher J; Hartwich G; Kredel L; Mayer M; Neidhardt B; von Oldershausen HF; Rösch W; Wahrendorf J Dtsch Med Wochenschr; 1979 Aug; 104(35):1231. PubMed ID: 383437 [TBL] [Abstract][Full Text] [Related]
3. Serum concentrations of 5-FU, ftorafur, and a major serum metabolite following ftorafur chemotherapy. Hornbeck CL; Griffiths JC; Floyd RA; Ginther NC; Byfield JE; Sharp TR Cancer Treat Rep; 1981; 65(1-2):69-72. PubMed ID: 6784923 [TBL] [Abstract][Full Text] [Related]
4. High-dose therapy with ftorafur in gastrointestinal cancer. Klein HO; Wickramanayake PD; Voigtmann R; Löffler T; Mohr R; Oerkermann H Recent Results Cancer Res; 1981; 79():65-81. PubMed ID: 6795700 [No Abstract] [Full Text] [Related]
5. Phase II trial of ftorafur with mitomycin C versus ftorafur with methyl-CCNU in untreated colorectal cancer. Buroker T; Wojtaszak B; Dindogru A; DeMattia M; Baker L; Groth C; Vaitkevicius VK Cancer Treat Rep; 1978 May; 62(5):689-92. PubMed ID: 350398 [TBL] [Abstract][Full Text] [Related]
6. Comparison of oral ftorafur and intravenous 5-fluorouracil in patients with advanced cancer of the stomach, colon or rectum. Bjerkeset T; Fjøsne HE Oncology; 1986; 43(4):212-5. PubMed ID: 3088506 [TBL] [Abstract][Full Text] [Related]
7. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors. Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450 [TBL] [Abstract][Full Text] [Related]
8. Phase I and pharmacologic study of oral ftorafur and X ray therapy in advanced gastrointestinal cancer. Byfield JE; Sharp TR; Hornbeck CL; Frankel SS; Floyd RA; Griffiths JC Int J Radiat Oncol Biol Phys; 1985 Mar; 11(3):597-602. PubMed ID: 3918971 [TBL] [Abstract][Full Text] [Related]
9. Phase I trial of ftorafur combined with mitomycin C or methyl-CCNU in gastrointestinal cancers. Buroker T; Baker L; Correa J; Schwartz LA; Vailtkevicius VK Cancer Treat Rep; 1977; 61(3):463-7. PubMed ID: 326403 [TBL] [Abstract][Full Text] [Related]
10. Comparison of 5-fluorouracil with ftorafur in adjuvant chemotherapies with combined inductive and maintenance therapies for gastric cancer. Nakajima T; Takahashi T; Takagi K; Kuno K; Kajitani T J Clin Oncol; 1984 Dec; 2(12):1366-71. PubMed ID: 6439835 [TBL] [Abstract][Full Text] [Related]
12. Improved liquid chromatographic assay for serum fluorouracil concentrations in the presence of ftorafur. Hornbeck CL; Floyd RA; Griffiths JC; Byfield JE J Pharm Sci; 1981 Oct; 70(10):1163-6. PubMed ID: 6795338 [TBL] [Abstract][Full Text] [Related]
13. An early phase II study of oral S-1, a newly developed 5-fluorouracil derivative for advanced and recurrent gastrointestinal cancers. The S-1 Gastrointestinal Cancer Study Group. Sugimachi K; Maehara Y; Horikoshi N; Shimada Y; Sakata Y; Mitachi Y; Taguchi T Oncology; 1999 Oct; 57(3):202-10. PubMed ID: 10545788 [TBL] [Abstract][Full Text] [Related]
14. Oral ftorafur versus intravenous 5-fluorouracil. A comparative study in patients with colorectal cancer. Andersen E; Pedersen H Acta Oncol; 1987; 26(6):433-6. PubMed ID: 3128309 [TBL] [Abstract][Full Text] [Related]
15. Ftorafur in the treatment of advanced malignancies. Shetty PA; De Souza LJ; Jussawalla DJ Indian J Cancer; 1982; 19(3):159-60. PubMed ID: 6816720 [No Abstract] [Full Text] [Related]
16. Pancreatic cancer treated with carmustine, fluorouracil, and spironolactone: a randomized study. Stephens RL; Hoogstraten B; Haas C; Clark G Arch Intern Med; 1978 Jan; 138(1):115-7. PubMed ID: 619817 [TBL] [Abstract][Full Text] [Related]
17. A comparative study of oral tegafur and intravenous 5-fluorouracil in patients with metastatic colorectal cancer. Bedikian AY; Stroehlein J; Korinek J; Karlin D; Bodey GP Am J Clin Oncol; 1983 Apr; 6(2):181-6. PubMed ID: 6402917 [TBL] [Abstract][Full Text] [Related]
18. Adriamycin, BCNU, ftorafur chemotherapy of pancreatic and biliary tract cancer. Hall SW; Benjamin RS; Murphy WK; Valdivieso M; Bodey GP Cancer; 1979 Dec; 44(6):2008-13. PubMed ID: 389404 [TBL] [Abstract][Full Text] [Related]
19. Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205). Ohtsu A; Shimada Y; Shirao K; Boku N; Hyodo I; Saito H; Yamamichi N; Miyata Y; Ikeda N; Yamamoto S; Fukuda H; Yoshida S; J Clin Oncol; 2003 Jan; 21(1):54-9. PubMed ID: 12506170 [TBL] [Abstract][Full Text] [Related]
20. Enhanced accumulation of 5-fluorouracil in human tumors in athymic mice by co-administration of Ftorafur and uracil. Tang SG; Hornbeck CL; Byfield JE Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1687-9. PubMed ID: 6434499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]